Navigation Links
Taiho Pharmaceutical présente une demande d'homologation pour la fabrication et la commercialisation du nouvel agent antitumoral TAS-102
Date:2/26/2013

) et dont le but ultime est l'enregistrement et l'immatriculation de cet agent.

Taiho Pharmaceutical croit que le TAS-102 apportera une contribution significative aux patients atteints de cancer et elle poursuivra ses efforts de développement afin d'en élargir son utilisation.

À propos de TAS-102

Le TAS-102 est un agent antitumoral, composé d'un mélange de Trifluorothymidine (FTD), un nucléoside qui s'intègre à l'ADN et inhibe de nombreuses fonctions génétiques requises pour la prolifération de cellules cancéreuses et de tipiracil hydrochloride (TPI), un inhibiteur de thymidine phosphorylase (qui dégrade la FTD) qui maintient une concentration sanguine effective de FTD. TAS-102 est administré par voie orale à raison de 70mg/m2/deux fois par jour durant cinq jours suivi de deux jours de repos, le tout répété deux fois. Après quoi les patients subissent une période de repos de 14 jours afin d'obtenir un cycle de 28 jours pour chaque essai.

À propos de l'essai clinique de phase II portant sur le TAS-102

L'essai de phase II a été effectué auprès de 172 patients dans 20 centres médicaux au Japon sur une période allant d'août 2009 à avril 2010. L'étude cible une condition pour laquelle il n'existe pas de thérapie pleinement établie - spécifiquement, chez les patients réfractaires à la chimiothérapie standard pour le traitement du cancer métastatique colorectal, ayant reçu au moins deux régimes contenant un mélange de fluoropyrimidine, d'irinotécan et d'oxaliplatine. Les patients ont reçu de manière aléatoire soit du TAS-102 (114 cas) ou un placebo (58 cas). L'indicateur principal de résultats final était le taux de survie général des patients.

À propos de l'essai clinique mondial de phas
'/>"/>

SOURCE Taiho Pharmaceutical Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
2. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Cowen & Company 33rd Annual Health Care Conference In Boston On March 5, 2013
4. Global Pharmaceutical Industry Trends: Procurement Budgets Stay the Same, Marketing Budgets to Experience Slight Decrease
5. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013
6. Savara Pharmaceuticals Announces Formation of Clinical Advisory Board
7. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
8. UBM Launches PharmaEvolution.com, an Online Peer-to-Peer Network for Pharmaceutical Industry Professionals
9. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
10. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
11. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Research and ... of the  "2015 Strategies in the UK ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... UK NAT laboratory practice, as well as ... trends with significant market impact during the ...
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ... Testing Market"  report to their offering.  ... ,This comprehensive report is designed to help ... and evaluate business opportunities emerging in the ...
(Date:5/27/2015)... , May 27, 2015  Actavis plc (NYSE: ... was approved by the Food and Drug Administration ... suffering from irritable bowel syndrome with diarrhea (IBS-D). ... is a mu receptor agonist, a delta receptor ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO "The ...
Breaking Medicine Technology:United States Hemostasis Diagnostic Testing Market Strategies 2015 2Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 2Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 3Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 4Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 5
... ChromaDex® Corp. (OTCBB: CDXC) today announced that the ... exclusive rights to a joint patent application filed ... of inducing UDP-glucuronosyltransferase (UGT) activity using pTeroPure®, ChromaDex®,s ... blueberries and demonstrated to have multiple health benefits. ...
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company ... Serverson, chief executive officer,  will present at 2011 Morgan ... 2011 at 10:20 a.m. ET at the Grand Hyatt ... markets and sells portable blood analysis systems for use ...
Cached Medicine Technology:ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers 2ChromaDex®'s Novel Ingredient pTeroPure® to be Studied as Potential Treatment for Fighting Skin Cancers 3Abaxis to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference 2
(Date:5/28/2015)... First Choice Emergency Room , ... the United States, announced that it is expanding in ... Valley Ranch facility. , “I am pleased to ... highest quality emergency medical care to Denver residents with ... Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:5/28/2015)... Dallas urologist Mark Allen, MD ... patient education website NORTHTEXASUROLOGIST.COM developed by ... readily access current educational information on various urological ... incontinence, prostate cancer treatment, robotic surgery and female ... to educate patients on urological conditions and treatments, ...
(Date:5/28/2015)... Omaha, NE (PRWEB) May 28, 2015 ... healthcare staffing, including nurse practitioner jobs, has announced that ... Association of Nurse Practitioners’ 2015 National Conference to be ... , AANP offers educational programming, networking opportunities, and ... Aureus Medical’s Advanced Practice division will be ...
(Date:5/28/2015)... The Cancer Solution: Taking Charge of Your Life ... heartfelt book the Booksandauthor reviewer ever read about ... writing what should be one of the most important books ... power in action and this book has both. , Cancer ... about and unfortunately many persons know little about it. Dr. ...
(Date:5/28/2015)... 28, 2015 The second episode of ... people who share a need to transform their lives. Josh ... Omaha, NE, struggling to deal with the death of his ... player from Kansas City, MO, who went into depression after ... amazing transformations will be featured in one episode of “Extreme ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room to Open New Facility in Denver, Colorado 2Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2Health News:Booksandauthor Cites The Cancer Solution as One of the Most Important Books to Read 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 3
... Using an unusual microscope with a tip the size ... look at tiny fibers of working muscles in live ... are sure to welcome. , This microendoscopy technique for ... of a meter longhas advantages over the uncomfortable alternative, ...
... leading global,provider of medical imaging and fusion software, announced ... imaging application for,iPhone and iPod touch on the Apple ... a doctor or patient to view medical,images remotely, without ... sitting with her patient, sharing images with him,iPhone to ...
... care are just a few of the extra costs ... In a new study that will be published in ... of social work at Washington University in St. Louis, ... their children,s special needs have different out-of-pocket health expenditures ...
... Agreement Further Positions the Company as a Weight Loss ... ... Inc. is pleased,to announce the signing of an exclusive license agreement for ... An endowed Guthrie Chair in Nutritional Sciences at The Pennsylvania,State University, Dr. ...
... P.C.,attorney Kenneth Watkins, announces that their client, Chantia ... arising out of a,sexual assault by defendant Dr. ... Ford Hospital Detroit Clinic, is now being cited ... and costs totaling over,$100,000.00. The sexual assault occurred ...
... for men is not good for women, study says , , ... or hurts your chances of avoiding heart disease and stroke ... you imbibe, a new study finds. , The report, which ... looked at the drinking habits and lifestyles of more than ...
Cached Medicine News:Health News:Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber 2Health News:MIM for the iPhone Is Available Free From the Apple App Store 2Health News:Cost of raising a child with special needs: Where does your state rank? 2Health News:Jenny Craig Establishes License Agreement for Volumetrics(R) 2Health News:Jenny Craig Establishes License Agreement for Volumetrics(R) 3Health News:Alcohol's Impact on Heart, Stroke Risk Differs by Gender 2
... Analyzer provides youwith new, exciting possibilities for ... WASCA Analyzeranalyzes the optical properties of the ... retina. In addition to refractive values, the ... which were largely ignored in the past. ...
... air flow modules are the economic solution ... work areas, which nevertheless present all the ... The modules can be easily installed in ... necessary to create sterile environment, without modifications ...
BRAT 2 Autologous Blood Recovery System gives performance, speed, versatility, and quality processing. , ,The BRAT 2 is now available with on-board Vacuum, programmability, plasma sequestration, Data...
The Wixson Hip Positioner is used for stable positioning of a patient during total hip and revision surgery. It is designed to be placed on top of the operating table....
Medicine Products: